{
    "code": "60000977",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=60000977",
    "time": "2022-07-15 07:28:22",
    "許可證字號": "衛部菌疫輸字第000977號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/09\/08",
    "發證日期": "104\/09\/08",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA06000097701",
    "中文品名": "安挺樂 皮下注射劑162毫克",
    "英文品名": "Actemra 162mg for SC Injection",
    "適應症": "1.1\t類風濕性關節炎(RA)\r\nActemra®合併methotrexate (MTX)可用於治療成年人中度至重度類風濕性關節炎，曾使用一種或一種以上之DMARD藥物治療或腫瘤壞死因子拮抗劑(TNF antagonist)治療而反應不佳或無法耐受的病人。在這些病人中，若病人對MTX無法耐受或不適合繼續投與MTX，可給Actemra®單獨治療。當 Actemra ®與MTX合併使用時，經 X光量測，可減緩關節傷害惡化速度，此外，經 HAQ-DI 量表評估，可改善生理功能。\r\n\r\n1.2\t巨細胞動脈炎(GCA)\r\nActemra®適用於治療成人巨細胞動脈炎(GCA)。",
    "劑型": "27D注射液劑",
    "包裝": "100支以下盒裝 0.9毫升預充塑膠針筒裝\/0.9毫升預充塑膠針筒裝附注射筆",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "109\/09\/08",
    "主成分略述": "Tocilizumab",
    "限制項目": "02輸　入",
    "申請商名稱": "1438501100  台灣中外製藥股份有限公司",
    "申請商地址": "台北市松山區敦化北路260號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "FJP0724000  UTSUNOMIYA PLANT OF CHUGAI PHARMA MANUFACTURING CO., LTD.",
            "製造廠廠址": "16-3 KIYOHARA KOGYODANCHI, UTSUNOMIYA-CITY, TOCHIGI, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "原料藥及成品製造廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013002800",
            "成分名稱": "Tocilizumab",
            "含量描述": "",
            "含量": "162.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "0203-Actemra SC安挺樂皮下注射劑_TPIv8-中文仿單 outline-109-02-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000977&Seq=009&Type=9"
        },
        {
            "title": "Approved ACT SC Artworks(G6)_核准外盒標籤-108-11-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000977&Seq=014&Type=8"
        },
        {
            "title": "Actemra SC-104-12-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=60000977&Seq=013&Type=8"
        }
    ]
}